These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. Sham HL; Zhao C; Stewart KD; Betebenner DA; Lin S; Park CH; Kong XP; Rosenbrook W; Herrin T; Madigan D; Vasavanonda S; Lyons N; Molla A; Saldivar A; Marsh KC; McDonald E; Wideburg NE; Denissen JF; Robins T; Kempf DJ; Plattner JJ; Norbeck DW J Med Chem; 1996 Jan; 39(2):392-7. PubMed ID: 8558507 [TBL] [Abstract][Full Text] [Related]
32. Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket. Hidaka K; Kimura T; Abdel-Rahman HM; Nguyen JT; McDaniel KF; Kohlbrenner WE; Molla A; Adachi M; Tamada T; Kuroki R; Katsuki N; Tanaka Y; Matsumoto H; Wang J; Hayashi Y; Kempf DJ; Kiso Y J Med Chem; 2009 Dec; 52(23):7604-17. PubMed ID: 19954246 [TBL] [Abstract][Full Text] [Related]
33. Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design. Perryman AL; Lin JH; Andrew McCammon J Chem Biol Drug Des; 2006 May; 67(5):336-45. PubMed ID: 16784458 [TBL] [Abstract][Full Text] [Related]
34. Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies. Bouzide A; Sauvé G; Yelle J Bioorg Med Chem Lett; 2005 Mar; 15(5):1509-13. PubMed ID: 15713418 [TBL] [Abstract][Full Text] [Related]
35. Design, biologic evaluation, and SAR of novel pseudo-peptide incorporating benzheterocycles as HIV-1 protease inhibitors. He M; Zhang H; Yao X; Eckart M; Zuo E; Yang M Chem Biol Drug Des; 2010 Aug; 76(2):174-80. PubMed ID: 20572811 [TBL] [Abstract][Full Text] [Related]
36. Stereoisomers of cyclic urea HIV-1 protease inhibitors: synthesis and binding affinities. Kaltenbach RF; Nugiel DA; Lam PY; Klabe RM; Seitz SP J Med Chem; 1998 Dec; 41(25):5113-7. PubMed ID: 9836627 [TBL] [Abstract][Full Text] [Related]
37. Multistage virtual screening and identification of novel HIV-1 protease inhibitors by integrating SVM, shape, pharmacophore and docking methods. Wei Y; Li J; Chen Z; Wang F; Huang W; Hong Z; Lin J Eur J Med Chem; 2015 Aug; 101():409-18. PubMed ID: 26185005 [TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure. Mimoto T; Nojima S; Terashima K; Takaku H; Shintani M; Hayashi H Bioorg Med Chem; 2008 Feb; 16(3):1299-308. PubMed ID: 17981045 [TBL] [Abstract][Full Text] [Related]
39. Novel strategies for targeting the dimerization interface of HIV protease with cross-linked interfacial peptides. Bowman MJ; Chmielewski J Biopolymers; 2002; 66(2):126-33. PubMed ID: 12325162 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chains. Smith AB; Charnley AK; Harada H; Beiger JJ; Cantin LD; Kenesky CS; Hirschmann R; Munshi S; Olsen DB; Stahlhut MW; Schleif WA; Kuo LC Bioorg Med Chem Lett; 2006 Feb; 16(4):859-63. PubMed ID: 16298527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]